177 related articles for article (PubMed ID: 33571226)
1. Guidance on the interpretation of faecal calprotectin levels in children.
Orfei M; Gasparetto M; Hensel KO; Zellweger F; Heuschkel RB; Zilbauer M
PLoS One; 2021; 16(2):e0246091. PubMed ID: 33571226
[TBL] [Abstract][Full Text] [Related]
2. [Fecal calprotectin as a biomarker to distinguish between organic and functional gastrointestinal disease].
Bonnín Tomàs A; Vila Vidal M; Rosell Camps A
Rev Esp Enferm Dig; 2007 Dec; 99(12):689-93. PubMed ID: 18290691
[TBL] [Abstract][Full Text] [Related]
3. Safely ruling out inflammatory bowel disease in children and teenagers without referral for endoscopy.
Van de Vijver E; Schreuder AB; Cnossen WR; Muller Kobold AC; van Rheenen PF;
Arch Dis Child; 2012 Dec; 97(12):1014-8. PubMed ID: 23019289
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Accuracy of Fecal Calprotectin for Pediatric Inflammatory Bowel Disease in Primary Care: A Prospective Cohort Study.
Holtman GA; Lisman-van Leeuwen Y; Kollen BJ; Norbruis OF; Escher JC; Kindermann A; de Rijke YB; van Rheenen PF; Berger MY
Ann Fam Med; 2016 Sep; 14(5):437-45. PubMed ID: 27621160
[TBL] [Abstract][Full Text] [Related]
5. Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy study.
Walker GJ; Chanchlani N; Thomas A; Lin S; Moore L; Heerasing NM; Hendy P; Abdelrahim M; Mole S; Perry MH; Mcdonald TJ; Bewshea CM; Hart JW; Russell RK; Ahmad T; Goodhand JR; Kennedy NA
Arch Dis Child; 2020 Oct; 105(10):957-963. PubMed ID: 32424002
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of fecal calprotectin in predicting an abnormal colonoscopy].
García Sánchez Mdel V; González R; Iglesias Flores E; Gómez Camacho F; Casais Juanena L; Cerezo Ruiz A; Montero Pérez-Barquero M; Muntané J; de Dios Vega JF
Med Clin (Barc); 2006 Jun; 127(2):41-6. PubMed ID: 16801001
[TBL] [Abstract][Full Text] [Related]
7. Clinical utility and outcome analysis of faecal calprotectin in Hawkes Bay District Health Board.
Bai W; Boswell T
N Z Med J; 2016 Apr; 129(1433):69-73. PubMed ID: 27349163
[TBL] [Abstract][Full Text] [Related]
8. Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy.
Huang VW; Prosser C; Kroeker KI; Wang H; Shalapay C; Dhami N; Fedorak DK; Halloran B; Dieleman LA; Goodman KJ; Fedorak RN
Inflamm Bowel Dis; 2015 Jun; 21(6):1359-67. PubMed ID: 25989340
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of point-of-care test calprotectin and lactoferrin for inflammatory bowel disease among children with chronic gastrointestinal symptoms.
Holtman GA; Lisman-van Leeuwen Y; van Rheenen PF; Kollen BJ; Escher JC; Kindermann A; de Rijke YB; Berger MY
Fam Pract; 2017 Aug; 34(4):400-406. PubMed ID: 27535331
[TBL] [Abstract][Full Text] [Related]
10. Faecal calprotectin effectively excludes inflammatory bowel disease in 789 symptomatic young adults with/without alarm symptoms: a prospective UK primary care cohort study.
Walker GJ; Moore L; Heerasing N; Hendy P; Perry MH; McDonald TJ; Debenham T; Bethune R; Bewshea C; Hyde C; Heap GA; Singh A; Calvert C; Kennedy NA; Goodhand JR; Ahmad T
Aliment Pharmacol Ther; 2018 Apr; 47(8):1103-1116. PubMed ID: 29508423
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic work-up of inflammatory bowel disease in children: the role of calprotectin assay.
Diamanti A; Panetta F; Basso MS; Forgione A; Colistro F; Bracci F; Papadatou B; Francalanci P; Torroni F; Knafelz D; Fina F; Castro M
Inflamm Bowel Dis; 2010 Nov; 16(11):1926-30. PubMed ID: 20310017
[TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin in suspected paediatric inflammatory bowel disease.
Degraeuwe PL; Beld MP; Ashorn M; Canani RB; Day AS; Diamanti A; Fagerberg UL; Henderson P; Kolho KL; Van de Vijver E; van Rheenen PF; Wilson DC; Kessels AG
J Pediatr Gastroenterol Nutr; 2015 Mar; 60(3):339-46. PubMed ID: 25373864
[TBL] [Abstract][Full Text] [Related]
13. Predicting inflammatory bowel disease in children with abdominal pain and diarrhoea: calgranulin-C versus calprotectin stool tests.
Heida A; Van de Vijver E; van Ravenzwaaij D; Van Biervliet S; Hummel TZ; Yuksel Z; Gonera-de Jong G; Schulenberg R; Muller Kobold A; van Rheenen PF;
Arch Dis Child; 2018 Jun; 103(6):565-571. PubMed ID: 29514815
[TBL] [Abstract][Full Text] [Related]
14. Value of Fecal Calprotectin as a Biomarker for Juvenile Polyps in Children Investigated With Colonoscopy.
Olafsdottir I; Nemeth A; Lörinc E; Toth E; Agardh D
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):43-6. PubMed ID: 26147630
[TBL] [Abstract][Full Text] [Related]
15. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children.
Olafsdottir E; Aksnes L; Fluge G; Berstad A
Acta Paediatr; 2002; 91(1):45-50. PubMed ID: 11883817
[TBL] [Abstract][Full Text] [Related]
16. Use of faecal immunochemical testing as an alternative to faecal calprotectin in children.
Sandhu K; Naik S; Ayling RM
Ann Clin Biochem; 2021 May; 58(3):230-235. PubMed ID: 33412889
[TBL] [Abstract][Full Text] [Related]
17. Clinical usefulness of the faecal calprotectin test in suspected paediatric inflammatory bowel disease.
Akobeng AK
Acta Paediatr; 2018 Nov; 107(11):2019-2023. PubMed ID: 29706011
[TBL] [Abstract][Full Text] [Related]
18. How to use faecal calprotectin in management of paediatric inflammatory bowel disease.
Saha A; Tighe MP; Batra A
Arch Dis Child Educ Pract Ed; 2016 Jun; 101(3):124-8. PubMed ID: 26848103
[TBL] [Abstract][Full Text] [Related]
19. Faecal calprotectin testing for identifying patients with organic gastrointestinal disease: systematic review and meta-analysis.
An YK; Prince D; Gardiner F; Neeman T; Linedale EC; Andrews JM; Connor S; Begun J
Med J Aust; 2019 Nov; 211(10):461-467. PubMed ID: 31680263
[TBL] [Abstract][Full Text] [Related]
20. The use of fecal calprotectin in monitoring activity of inflammatory bowel diseases.
Knyazev OV; Kagramanova AV; Korneeva IA; Noskova KK; Belousov SV; Parfenov AI
Ter Arkh; 2019 May; 91(4):53-61. PubMed ID: 31094477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
